EGFR and lung cancer: In NSCLC, upregulated vimentin, EMT‐related transcription factors (e.g., ZEB1, Slug), and downregulated E‐cadherin are associated with promotion of EMT, thereby increasing lung cancer resistance to EGFR‐TKIs.116, 117, 118